Skip to main content

iwCLL 2025 Main banner

iwCLL X / Twitter

121 Views

Poster

1401 - Risk of Second Primary Malignancies in Patients with Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Receiving First-line Therapy: A Real-World Study

Primary Author / Presenter(s)

VB

Vanthana Bharathi, MD

MD Anderson Cancer Center
Houston, Texas, United States

Co-Author(s)

LZ

Lili Zhou, PhD

BeOne Medicines Ltd
San Carlos, California, United States
AA

Ayad K. Ali, PhD

BeOne Medicines Ltd
San Carlos, California, United States
QF

Qianhong Fu, MS

BeOne Medicines Ltd
San Carlos, California, United States
WA

Wassim Aldairy, MD, PhD

BeOne Medicines Ltd
San Carlos, California, United States
AF

Alessandra Ferrajoli, MD

Professor
UT MD Anderson Cancer Center
Houston,, Texas, United States